@MarkFariesMD

Surgical Oncologist Melanoma Surgeon Cancer Research Immunotherapy

 Los Angeles, CA
theangelesclinic.org
Joined October 2017
  • Tweets22
  • Following196
  • Followers361
6Media
Prof @OmidHamidMD the southern #California ROCKSTAR #Immunotherapist “You always hurt the one you love” - need to optimize Ipi dose #Bridge18
1
3
1
10
Congratulations to @RobertAndtbacka for leading/presenting the neoadjuvant T-VEC study. cancernetwork.com/news/t-vec…
1
6
MarkFariesMD retweeted
Cedars-Sinai@CedarsSinai3 Jun 2018
On #CancerSurvivorsDay, we celebrate our patients who have beaten #cancer. Our staff has this message for you!
6
3
22
.@JeffGershenwald @MarkFariesMD & colleagues review the evidence-based changes in the @AJCCancer 8th edition #Melanoma staging guidelines onlinelibrary.wiley.com/doi/…
4
1
7
Prof Nicola Mozzillo melanoma surgeon extraordinaire receives award from Dr @PAscierto for decades of leadership and advancing treatments to #FINISHCANCER / Dr Mozzillo’s address remembers Dr Don Morton @JohnWayneCI & @Prov_Health #Bridge2017 @FondMelanoma thanks @MarkFariesMD
3
6
Sunrise over LA. Heading to Stanford for Eye Am Not Alone conference. #ocularmelanoma Looks like a great meeting.
4
Great doctor and great person, Dr. Ann Partridge ( @YoungStrongDFCI ) featured in ASCO post. Great job Ann!
4
John Wayne alumni fellow Vern Sondak co - chairing plenary session at # worldcongressofmelanoma
4
Nice work! @jasonlukemd giving great talk on what's next in immunotherapy. #worldmelanomacongress
3
Just published (finally!) the Canvaxin trial in Stage IV melanoma. A testament to Don Morton's tenacity. ncbi.nlm.nih.gov/pubmed/2901…

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant...

In this, the largest study of postsurgical adjuvant therapy for stage IV melanoma reported to date, BCG/Cv did not improve outcomes over BCG/placebo. Favorable long-term survival among study patients...

pubmed.ncbi.nlm.nih.gov
1
4
2
9
Wanted to notify all of Twitter that I am seeing patients @theangelesclinic direct 310-231-2164 - email [email protected] #melanoma #melasm #immunotherapy #SurgOnc #ImmunoOnc #immunooncology #PD1 #clinicaltrials
3
6
Load more